iloprost and Cerebral-Infarction

iloprost has been researched along with Cerebral-Infarction* in 1 studies

Other Studies

1 other study(ies) available for iloprost and Cerebral-Infarction

ArticleYear
Effect of the prostacyclin analogue, iloprost, on infarct size after permanent focal cerebral ischemia.
    General pharmacology, 1996, Volume: 27, Issue:7

    This investigation was undertaken to study the effect of iloprost, a stable analogue of prostacyclin, on infarct size after permanent focal cerebral ischemia in the rabbit. Forty-two adult rabbits were subjected to left middle cerebral artery occlusion via the transorbital route. Fourteen rabbits received an intravenous (i.v.) infusion of 30 micrograms/kg iloprost, 7 rabbits received an i.v. infusion of 10 micrograms/ kg, and 9 rabbits received an i.v. infusion of 20 micrograms/kg iloprost. Twelve rabbits received an intravenous infusion of saline. Treatment with iloprost started immediately after middle cerebral artery occlusion and continued for 1 h. After killing the animals, brains were removed and five coronal slices were incubated in a 2,3,5-triphenyltetrazolium chloride solution to determine the infarct size. Treatment with 30 micrograms/kg iloprost significantly reduced the infarct size compared with treatment with saline (3.49 +/- 2.79% vs. 9.03 +/- 4.26%, P < 0.001), but the lower doses of iloprost did not have a beneficial effect on the size of the infarct. These results suggest that intravenous iloprost treatment after occlusion has a highly protective effect without any side effects such as hypotension.

    Topics: Animals; Brain; Brain Ischemia; Cerebral Infarction; Hemodynamics; Iloprost; Rabbits; Respiratory Mechanics; Vasodilator Agents

1996